Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

Literature DB >> 18808988

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

Paola Cinque¹, Bruce J Brew, Magnus Gisslen, Lars Hagberg, Richard W Price.

Abstract

Entities: Disease

Year: 2007 PMID： 18808988 DOI： 10.1016/S0072-9752(07)85017-2

Source DB: PubMed Journal: Handb Clin Neurol ISSN： 0072-9752

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.

Authors: Michael J Peluso; Serena Spudich
Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071

2. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Authors: Viktor Dahl; Julia Peterson; Dietmar Fuchs; Magnus Gisslen; Sarah Palmer; Richard W Price
Journal: AIDS Date: 2014-09-24 Impact factor: 4.177

3. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors: Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal: Neurology Date: 2014-09-26 Impact factor: 9.910

4. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.

Authors: Sergio M de Almeida; Indianara Rotta; Yanxin Jiang; Xiao Li; Sonia M Raboni; Clea E Ribeiro; Davey Smith; Michael Potter; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal: J Neurovirol Date: 2016-07-11 Impact factor: 2.643

5. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients.

Authors: Claudia Landi; Letizia Santinelli; Laura Bianchi; Enxhi Shaba; Giancarlo Ceccarelli; Eugenio Nelson Cavallari; Cristian Borrazzo; Claudia Pinacchio; Carolina Scagnolari; Vincenzo Vullo; Luca Bini; Gabriella d'Ettorre
Journal: J Neurovirol Date: 2019-11-01 Impact factor: 2.643

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

1. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.

2. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

3. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

4. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.

5. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients.

6. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

7. Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.

Review 8. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.

Review 9. Antiretroviral therapy and central nervous system HIV type 1 infection.

Review 10. HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.